Asymptomatic QTc prolongation during coadministration of aripiprazole and haloperidol

J Clin Psychiatry. 2008 Feb;69(2):327-8. doi: 10.4088/jcp.v69n0221d.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antipsychotic Agents / administration & dosage
  • Antipsychotic Agents / adverse effects*
  • Antipsychotic Agents / pharmacokinetics
  • Aripiprazole
  • Cytochrome P-450 Enzyme System / metabolism
  • Drug Therapy, Combination
  • Electrocardiography
  • Female
  • Haloperidol / administration & dosage
  • Haloperidol / adverse effects*
  • Haloperidol / pharmacokinetics
  • Heart Conduction System / drug effects*
  • Heart Conduction System / physiopathology
  • Humans
  • Long QT Syndrome / chemically induced*
  • Long QT Syndrome / physiopathology
  • Piperazines / administration & dosage
  • Piperazines / adverse effects*
  • Piperazines / pharmacokinetics
  • Quinolones / administration & dosage
  • Quinolones / adverse effects*
  • Quinolones / pharmacokinetics
  • Schizophrenia / drug therapy
  • Schizophrenia / physiopathology

Substances

  • Antipsychotic Agents
  • Piperazines
  • Quinolones
  • Aripiprazole
  • Cytochrome P-450 Enzyme System
  • Haloperidol